(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Cost of revenue | ||||||||||
Gross profit | ||||||||||
Operating expense | -2.79%153.21K | -70.80%78.16K | -65.22%79.81K | -82.39%562.02K | -108.94%-92.79K | -89.29%157.61K | -38.90%267.72K | -6.01%229.47K | 292.09%3.19M | 97.25%1.04M |
Selling and administrative expenses | -24.99%27.62K | -51.14%24.68K | -54.13%27.22K | -60.07%186.18K | -67.41%39.51K | -83.04%36.83K | 13.53%50.5K | 9.07%59.35K | 49.48%466.24K | 13.71%121.23K |
-General and administrative expense | -24.99%27.62K | -51.14%24.68K | -54.13%27.22K | -60.07%186.18K | -67.41%39.51K | -83.04%36.83K | 13.53%50.5K | 9.07%59.35K | 49.48%466.24K | 13.71%121.23K |
Research and development costs | --0 | --0 | ---- | -88.80%42.03K | -81.34%35.69K | --0 | -86.82%6.34K | ---- | 196.15%375.36K | --191.26K |
Other operating expenses | 3.97%125.58K | -74.64%53.49K | -69.09%52.59K | -85.79%333.81K | -123.15%-167.99K | -90.06%120.78K | -38.99%210.88K | 84.61%170.13K | 526.09%2.35M | 147.69%725.74K |
Operating profit | 2.79%-153.21K | 70.80%-78.16K | 65.22%-79.81K | 82.39%-562.02K | 108.94%92.79K | 89.29%-157.61K | 38.90%-267.72K | 6.01%-229.47K | -292.09%-3.19M | -97.25%-1.04M |
Net non-operating interest income (expenses) | 0 | 0 | ||||||||
Non-operating interest income | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Other net income (expenses) | 3.14K | -95.04%1.06K | 13.04K | -8.36K | 21.4K | |||||
Gain on sale of security | ---- | ---- | ---- | ---8.36K | ---- | ---- | ---- | ---- | ---- | ---- |
Other non-operating income (expenses) | --3.14K | ---- | -95.04%1.06K | --21.4K | --0 | ---- | ---- | --21.4K | ---- | ---- |
Income before tax | 4.78%-150.07K | 70.80%-78.16K | 62.15%-78.75K | 82.80%-548.98K | 108.06%83.65K | 89.29%-157.61K | 38.90%-267.72K | 14.77%-208.07K | -292.09%-3.19M | -97.25%-1.04M |
Income tax | ||||||||||
Earnings from equity interest net of tax | ||||||||||
Net income | 4.78%-150.07K | 70.80%-78.16K | 62.15%-78.75K | 82.80%-548.98K | 108.06%83.65K | 89.29%-157.61K | 38.90%-267.72K | 14.77%-208.07K | -292.09%-3.19M | -97.25%-1.04M |
Net income continuous operations | 4.78%-150.07K | 70.80%-78.16K | 62.15%-78.75K | 82.80%-548.98K | 108.06%83.65K | 89.29%-157.61K | 38.90%-267.72K | 14.77%-208.07K | -292.09%-3.19M | -97.25%-1.04M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 4.78%-150.07K | 70.80%-78.16K | 62.15%-78.75K | 82.80%-548.98K | 108.06%83.65K | 89.29%-157.61K | 38.90%-267.72K | 14.77%-208.07K | -292.09%-3.19M | -97.25%-1.04M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | ||||||||||
Net income attributable to common stockholders | 4.78%-150.07K | 70.80%-78.16K | 62.15%-78.75K | 82.80%-548.98K | 108.06%83.65K | 89.29%-157.61K | 38.90%-267.72K | 14.77%-208.07K | -292.09%-3.19M | -97.25%-1.04M |
Diluted earnings per share | 0.00%-0.002 | 90.00%-0.001 | 75.00%-0.001 | 14.29%-0.06 | -190.00%-0.058 | 93.33%-0.002 | 0.00%-0.01 | 60.00%-0.004 | -250.00%-0.07 | -100.00%-0.02 |
Basic earnings per share | 0.00%-0.002 | 90.00%-0.001 | 75.00%-0.001 | 14.29%-0.06 | -190.00%-0.058 | 93.33%-0.002 | 0.00%-0.01 | 60.00%-0.004 | -250.00%-0.07 | -100.00%-0.02 |
Dividend per share | ||||||||||
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data